Pharmaceutical Technology is the only peer-reviewed publication serving the largest requested circulation of 38,600 BPA-audited subscribers (June 2010 BPA Statement). Here is the November editorial lineup to give you a heads up on the coverage in this issue and to assist you in your decision to advertise in Pharmaceutical Technology this month.

Ad close is October 1 and your ad materials will be due on October 13.

EDITORIAL PREVIEW
November 2010
Editorial Content Subject To Change

Pharma Ingredients Report: APIs and Excipients: Solid State Chemistry
Patricia Van Arnum, senior editor, Pharmaceutical Technology

Technical Note: Solutol HS 15, a Solubilizing Novel Excipient: Identification of the Need and Implementation of Regulatory Strategy in US
James Agalloco, Agalloco & Associates, and member of PharmTech Editorial Board

Position Paper: The Importance of Equivalence in the Execution & Maintenance of Validation Activities
M. Sherry Ku, Ph.D., President and CSO, Anchen Pharmaceuticals, Irvine, California AND Ranga Velagaleti, Ph.D., Manager, Regulatory Affairs, North America, Pharma Ingredients and Services, BASF Corporation, Florham Park, NJ

PEER REVIEWED RESEARCH
PAT - A Proposed Content Uniformity Test for Large Sample Sizes

BIOAVAILABILITY AND TABLETING - Development of orally-disintegrating tablets using starch and fructose

DRUG DELIVERY - Development of an Osmotically Controlled Drug-Delivery System of Glipizide using Hydroxypropl-B-Cyclodextrin